ARTICLE | Distillery Techniques
Drug platforms
April 10, 2018 11:02 PM UTC
HSPCs derived from iPS cells and engineered to express the MLL-AF4 fusion oncogene could improve the engraftment of HSPC transplant therapies. The HSPCs were generated by inducing differentiation of i...
BCIQ Company Profiles
BCIQ Target Profiles